OpenFilings

REGENERON PHARMACEUTICALS, INC.

Form10-K

Report Period2020-12-31

Date Filed2021-02-08

Time Filed09:13:00

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
STOCK OPTION AGREEMENT (NQ) - EXECUTIVE OFFICERS
STOCK OPTION AGREEMENT (NQ) - P. ROY VAGELOS
RESTRICTED STOCK AGREEMENT - EXECUTIVE OFFICERS
RESTRICTED STOCK AGREEMENT - P. ROY VAGELOS
STOCK OPTION AGREEMENT (NQ) - NON-EMPLOYEE DIRECTORS
RESTRICTED STOCK AGREEMENT - NON-EMPLOYEE DIRECTORS
PERFORMANCE RESTRICTED STOCK UNIT AGREEMENT
PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI
MODIFICATION 01 TO PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI
MODIFICATION 02 TO PROJECT AGREEMENT BY AND BETWEEN THE REGISTRANT AND ATI
SUBSIDIARIES OF THE REGISTRANT
CONSENT OF PRICEWATERHOUSECOOPERS LLP
CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)
CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350
Filing on SEC Edgar